1. Executive Summary
2. Research Methodology
3. Osteoarthritis
3.1 Overview
3.1.1 Symptoms
3.1.2 Diagnosis
3.2 Treatment
3.2.1 Corticosteroids
3.2.2 Hyaluronic Acid Injections
3.2.3 Viscosupplementation
4. Viscosupplementation
4.1 Overview
4.1.1 Synthesis
4.2 Procedure
4.2.1 Single Injection
4.2.2 Three Injection
4.2.3 Five Injection
4.3 Applications
5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Procedure Type
5.2.2 Market Share by Hyaluronic Acid Type
5.2.3 Market Share by Application
5.2.4 Market Share by End-Users
5.2.5 Market Share by Region
6. Market Segmentation - Procedure
6.1 Single injection
6.1.1 Market Size by Value (Actual & Forecasted)
6.2 Three injection
6.2.1 Market Size by Value (Actual & Forecasted)
6.3 Five injection
6.3.1 Market Size by Value (Actual & Forecasted)
7. Regional Analysis
7.1 North America
7.1.1 Market Sizing (Actual & Forecasted)
7.1.2 The US
7.1.2.1 Market Size by Value (Actual & Forecasted)
7.1.2.2 Market Size by Volume (Actual & Forecasted)
7.1.2.3 Market Share by Product
7.2 Asia Pacific
7.2.1 Market Sizing (Actual & Forecasted)
7.3 Europe
7.3.1 Market Sizing (Actual & Forecasted)
8. Market Dynamics
8.1 Industry Trends & Developments
8.1.1 Advent of Combination Therapeutic Products
8.1.2 Launch of New Products
8.1.3 Rise in Number of Distribution Agreements
8.2 Growth Drivers
8.2.1 Increasing Geriatric Population
8.2.2 Prevalence of Arthritis
8.2.3 High Demand from Emerging Nations
8.2.4 Rising Public Awareness
8.3 Challenges
8.3.1 Stringent Regulations
8.3.2 Unfavorable Reimbursement Policies
8.3.3 Adverse Side-Effects
9. Competitive Landscape
9.1 Financial Analysis
9.2 Products Portfolio
9.3 Market Share Analysis
10. Company Profiles
10.1 Sanofi Genzyme
10.2 Anika Therapeutics, Inc.
10.3 Seikagaku Corporation
10.4 Zimmer Biomet Holdings Inc.
10.5 Smith & Nephew Plc